학술논문
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial
Document Type
Academic Journal
Author
Source
Annals of Oncology. Dec 01, 2017 28(12):3110-3110
Subject
Language
English
ISSN
0923-7534